Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City [PDF]
, 2012 Christian Díaz de León-Castañeda, Marina Altagracia-Martínez, Jaime Kravzov-Jinich, Ma del Rosario Cárdenas-Elizalde, Consuelo Moreno-Bonett, Juan Manuel Martínez-Núñ ...
Cárdenas-Elizalde MR +5 more
core
Treatment of gestational diabetes: oral hypoglycemic agents or insulin? [PDF]
, 2011 Our report aims to verify whether perinatal maternal glycemic control in gestational diabetes can only be achieved with insulin or with oral hypoglycemic agents.
Renda, Eliana +7 more
core
Disparity in cost of oral hypoglycemic agents available in Indian market [PDF]
, 2019 Background: Diabetes is one of the most common non-communicable disease worldwide, of which India has been crowned with the title of “diabetes capital of the world”. On an average a person spends 20% of his or her income for the treatment of diabetes per
., Soni +2 more
core +2 more sources
Journal of Nepal Medical Association, 2021 Introduction: Drug-drug interaction is one of the causes of adverse drug reactions. Generally, drug-drug interaction is common in multidrug therapy.
Lujaw Ratna Tuladhar +4 more
doaj +1 more source
EFFECT OF CHLOROQUINE ON BLOOD GLUCOSE LEVELS IN PATIENTS WITH NON INSULIN DEPENDENT DIABETES MELLITUS [PDF]
Acta Medica Iranica, 1998 77irty six patients with non insulin dependent diabetes mellitus, whose blood sugar was not controlled with maximal doses of oral hypoglycemic agents and did not accept insulin treatment, were selected for this study.
H. Mostafavi
doaj +1 more source
Vildagliptin and its role in the treatment of diabetes mellitus
Сахарный диабет, 2010 Type 2 diabetes mellitus is a most serious medical problem throughout the world. Traditional hypoglycemic agents do not ensure long-term control ofglycemia and fail to affect the natural course of DM.
Yury Shavkatovich Khalimov
doaj +1 more source
Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations
Drug Design, Development and Therapy, 2016 Minhui Hu,1 Chunlan Zheng,1 Feng Gao2 1Department of Internal Medicine – Section 5, Wuhan Pulmonary Hospital (Wuhan Tuberculosis Control Institute), 2Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of ...
Hu MH, Zheng CL, Gao F
doaj
How Many Diabetes Patients Know the Name of Hypoglycemic Agents They Are Taking? [PDF]
, 2017 Background: Numerous diabetes patients do not know the name of hypoglycemic agents that they are taking, even though they have taken them for a long time. The aim of this study was to find out the percentage of diabetes patients who recognize the name of
김경곤 +3 more
core
Meta-regression analysis of the association between baseline BMI and the efficacy in HbA1c change in total seven hypoglycemic agents. [PDF]
, 2016 Meta-regression analysis of the association between baseline BMI and the efficacy in HbA1c change in total seven hypoglycemic agents.
Xiaoling Cai (319173) +5 more
core +1 more source
Рациональная фармакотерапия в кардиологии, 2016 The classic hypoglycemic agents include biguanides, sulfonylurea drugs, meglitinides, glitazones and alpha-glucosidase inhibitors. Modern algorithm of hypoglycemic therapy in the first step considers lifestyle modification and metformin monotherapy, the ...
A. A. Aleksandrov
doaj +1 more source